These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11231834)

  • 1. Sleep and sleep electroencephalogram in depressed patients treated with phenelzine.
    Landolt HP; Raimo EB; Schnierow BJ; Kelsoe JR; Rapaport MH; Gillin JC
    Arch Gen Psychiatry; 2001 Mar; 58(3):268-76. PubMed ID: 11231834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.
    Landolt HP; Gillin JC
    Neuropsychopharmacology; 2002 Sep; 27(3):462-9. PubMed ID: 12225703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
    Landolt HP; de Boer LP
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.
    Landolt HP; Kelsoe JR; Rapaport MH; Gillin JC
    J Sleep Res; 2003 Mar; 12(1):13-8. PubMed ID: 12603782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
    J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients.
    Wyatt RJ; Fram DH; Kupfer DJ; Snyder F
    Arch Gen Psychiatry; 1971 Feb; 24(2):145-55. PubMed ID: 4321956
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
    Wyatt RJ; Fram DH; Buchbinder R; Snyder F
    N Engl J Med; 1971 Oct; 285(18):987-91. PubMed ID: 4328710
    [No Abstract]   [Full Text] [Related]  

  • 8. Mood and sleep changes with monoamine-oxidase inhibitors.
    Dunleavy DL
    Proc R Soc Med; 1973 Sep; 66(9):951. PubMed ID: 4375816
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenelzine, mood response, and sleep.
    Dunleavy DL; Oswald I
    Arch Gen Psychiatry; 1973 Mar; 28(3):353-6. PubMed ID: 4347382
    [No Abstract]   [Full Text] [Related]  

  • 10. Age effects on spectral electroencephalogram activity prior to dream recall.
    Chellappa SL; Münch M; Knoblauch V; Cajochen C
    J Sleep Res; 2012 Jun; 21(3):247-56. PubMed ID: 21851439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone.
    Van Bemmel AL; Beersma DG; Van den Hoofdakker RH
    J Affect Disord; 1995 Oct; 35(1-2):11-9. PubMed ID: 8557883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers.
    Tribl GG; Wetter TC; Schredl M
    Sleep Med Rev; 2013 Apr; 17(2):133-42. PubMed ID: 22800769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REM sleep suppression induced by selective monoamine oxidase inhibitors.
    Cohen RM; Pickar D; Garnett D; Lipper S; Gillin JC; Murphy DL
    Psychopharmacology (Berl); 1982; 78(2):137-40. PubMed ID: 6817370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide.
    Minot R; Luthringer R; Macher JP
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):181-9. PubMed ID: 8468440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep, natural and unnatural.
    Oswald I
    Proc R Soc Med; 1969 Sep; 62(9):901-3. PubMed ID: 4310658
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG activities during elicited sleep onset REM and NREM periods reflect different mechanisms of dream generation. Electroencephalograms. Rapid eye movement.
    Takeuchi T; Ogilvie RD; Murphy TI; Ferrelli AV
    Clin Neurophysiol; 2003 Feb; 114(2):210-20. PubMed ID: 12559227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.
    Riemann D; Löw H; Schredl M; Wiegand M; Dippel B; Berger M
    Psychiatr J Univ Ott; 1990 Jun; 15(2):93-9. PubMed ID: 2374795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trimipramine on dream recall and dream emotions in depressive outpatients.
    Schredl M; Berger M; Riemann D
    Psychiatry Res; 2009 May; 167(3):279-86. PubMed ID: 19403177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.